Using the multivariate Cox model, SLC11A1 was also an independent determinant [high vs. low HR=2.33, 95% CI (1.92-2.58)] of the outcomes of glioma patients after controlling for grade, IDH status, age, chemotherapy status and recurrence (Figure 4A). Here, SLC11A1 is linked to central nervous system cancer.